User blogs

The global Monoclonal Antibody Therapy market, valued at USD 87.8 billion in 2023, is projected to witness substantial growth, reaching USD 230.38 billion by 2031. This growth represents a robust compound annual growth rate (CAGR) of 12.8% during the forecast period from 2024 to 2031.Monoclonal antibodies (mAbs) play a pivotal role in the treatment of various diseases, including cancer, autoimmune disorders, infectious diseases, and more. They are highly specific and can target specific cells or proteins involved in disease... more

Mononucleosis Diagnostic Market AnalysisThe Mononucleosis Diagnostic Market size was estimated at USD 1.7 billion in 2022 and is expected to reach USD 3.2 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.6% during the forecast period from 2023 to 2030.Mononucleosis, caused by the Epstein-Barr virus (EBV), is a common viral infection that affects a large number of individuals globally. Diagnostic tests for mononucleosis are crucial for accurate and timely detection, which is essential for appropriate patient manag... more

Monoclonal Antibody Therapy Market AnalysisThe Monoclonal Antibody Therapy Market size was valued at USD 87.8 billion in 2023 and is expected to reach USD 230.38 billion by 2031, growing at a compound annual growth rate (CAGR) of 12.8% over the forecast period from 2024 to 2031.Monoclonal antibody therapy involves using laboratory-made antibodies that can bind to specific targets in the body, such as cancer cells. These therapies are increasingly being used to treat a variety of conditions, including cancers, autoimmune diseases, and... more